Compositions and methods for treatment of non-Hodgkin's lymphoma
AssigneeGenentech, Inc.
InventorsAvi J. Ashkenazi, Dylan L. Daniel, Theresa Shek
Life of this patent
Estimating the term…
Abstract
The present invention is directed to compositions of matter useful for the treatment of non-Hodgkin's lymphoma in mammals and to methods of using those compositions for the same.
Claims15
A method for inhibiting the growth of a non-Hodgkin's lymphoma cell in vitro that overexpresses a polypeptide, wherein the polypeptide comprises an amino acid sequence selected from (i) the amino acid sequence of SEQ ID NO:2, (ii) the amino acid sequence of SEQ ID NO:2, lacking its siginal peptide, and (iii) an amino acid sequence resulting from enzymatic cleavage of (i) or (ii) with a proprotein convertase, the method comprising contacting the non-Hodgkin's lymphoma cell with an antibody that (a) specifically binds to the polypeptide that is bound to the surface of the non-Hodgkin's lymphoma cell and (b) does not inhibit binding of the polypeptide to the non-Hodgkin's lymphoma cell, and wherein the antibody is conjugated to a therapeutic agent that inhibits the growth of the non-Hodgkin's lymphoma cell.
Dependencies are inferred from the claim text.